Are women content with provoked abortion as home treatment?;Provosert abort som hjemmebehandling

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 18, 2007, Pages 2367-2370

  Jørgensen, Hilde ^a   Qvigstad, Erik ^b   Jerve, Fridtjof ^a   Melseth, Eldbjørg ^a   Eskild, Anne ^c   Nielsen, Christopher S ^d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d NONE   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; DRUG SELF ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; PATIENT EDUCATION; PATIENT SATISFACTION; PREGNANCY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SELF CARE; SOCIOECONOMICS;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIFEPRISTONE; MISOPROSTOL; PATIENT EDUCATION; PATIENT SATISFACTION; PREGNANCY; QUESTIONNAIRES; SELF ADMINISTRATION; SELF CARE; SOCIOECONOMIC FACTORS;

EID: 35348922875     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fiala C, Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 2006; 74: 66-86.
2. von Hertzen H, Honkanen H, Piaggio G et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. BJOG 2003; 110: 808-18.
3. Schaff EA, Fielding SL, Eisinger SH et al. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000; 61: 41-6.
4. Guengant JP, Bangou J, Elul B et al. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Contraception 1999; 60: 167-72.
5. Elul B, Hajri S, Ngoc NN et al. Can women in less-developed countries use a simplified abortion regimen? Lancet 2001; 357: 1402-5.
6. Fiala C, Winikoff B, Helstrom L et al. Acceptability of home-use of misoprostol in medical abortion. Contraception 2004; 70: 387-92.
7. Henderson JT, Hwang AC, Harper CC et al. Safety of mifepristone abortions in clinical use. Contraception 2005; 72: 175-8.
8. Fielding SL, Edmunds E, Schaff EA. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences. Perspect Sex Reprod Health 2002; 34: 34-40.
9. Slade P, Heke S, Fletcher J et al. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care. Br J Obstet Gynaecol 1998; 105: 1288-95.
10. Berer M. Medical abortion: issues of choice and acceptability. Reprod Health Matters 2005; 13: 25-34.
11. Spielberger CD, Gorsuch DL, Lushine RL. Manual for the state trait anxiety inventory. Palo Alto, CA: Consulting Psychologist Press, 1970.
12. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. I: Melzack R, Turk DC, red. Handbook of pain assessment. London: Guilford Press, 2001: 15-34.
13. Wiebe E. Pain control in medical abortion. Int J Gynaecol Obstet 2001; 74: 275-80.
14. Nielsen CS, Price DD, Vassend O et al. Characterizing individual differences in heat-pain sensitivity. Pain 2005; 119: 65-74.